11th CAR-TCR Summit

ABOUT THE EVENT

Date: September 14, 2026 8am - September 16, 2026 6pm EDT
Event Location: Boston , Massachusetts

The cell therapy field is entering a more demanding phase, with focus shifting from early momentum to long-term commercial success. Attention is turning to novel innovations like in vivo therapies and automated manufacturing: two game-changing strategies that promise to cut costs, speed up development, and unlock commercial viability. With more than $6.6 billion invested in the last six months from the likes of AbbVie and Kite, investor confidence is returning, but with clear expectations. It’s critical to adapt to this next wave of innovation where standout clinical data and scalable platforms are non-negotiable.

The 11th CAR-TCR Summit is your must attend forum, bringing together the latest scientific innovation across therapeutic classes and indications to inform your business strategy and support long term commercial success. Renowned for its caliber of networking and unparalleled depth of content, expect cutting-edge clinical data on ex vivo and in vivo advances, clinical trial strategies to support expanded patient access across indications, scalable and automated manufacturing processes to improve speed and costs, as well as commercial reflections to learn from those on the market.

MORE EVENTS
Learn what manufacturing challenges lie ahead, how to equip your team to protect your program from avoidable manufacturing and regulatory setbacks and forge partnerships that can withstand the next five years of industry turbulence.
Wednesday, September 16, 2026 1–2pm EDT
 · 
Virtual
In this webinar, experts from SK pharmteco’s European and North American sites will share practical experience addressing these challenges across the linker-payload development lifecycle—from facility and containment strategy through process and analytical development, scale-up, cleaning, and final product release. Case-based examples will illustrate how integrated chemistry, engineering, analytical, and industrial hygiene strategies can reduce technical risk and support the rapid transition of emerging ADC programs into GMP manufacturing.
Tuesday, September 29, 2026 11am–12pm EDT
 · 
Virtual